Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H20O2 |
Molecular Weight | 232.3181 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C(O)=O)C1=CC=C(C=C1)C2CCCCC2
InChI
InChIKey=YTUMWOBUZOYYJQ-UHFFFAOYSA-N
InChI=1S/C15H20O2/c1-11(15(16)17)12-7-9-14(10-8-12)13-5-3-2-4-6-13/h7-11,13H,2-6H2,1H3,(H,16,17)
Molecular Formula | C15H20O2 |
Molecular Weight | 232.3181 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2739811
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2739811
Hexaprofen, a potent anti-inflammatory agent, is an inhibitor of platelet aggregation. Experiments on mice have shown that hexaprofen could reduce the quantity and size of Lewis lung carcinoma (LLC) tumor nodules.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:25:58 GMT 2023
by
admin
on
Sat Dec 16 16:25:58 GMT 2023
|
Record UNII |
H2F4OV65RN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083976
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
246-379-8
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
3490
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
24645-20-3
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL244138
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
71703
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
SUB08031MIG
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
C83751
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
DTXSID901030988
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY | |||
|
H2F4OV65RN
Created by
admin on Sat Dec 16 16:25:58 GMT 2023 , Edited by admin on Sat Dec 16 16:25:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |